Plasma Lipoprotein Induction and Suppression of the Generation of Cellular Procoagulant Activity in Vitro: REQUIREMENTS FOR CELLULAR COLLABORATION

Por Levy, Gary A., Schwartz, Bradford S., Curtiss, Linda K., Edgington, Thomas S.
Publicado em 1981

Structural Differences between Active Forms of Plasminogen Activator Inhibitor Type 1 Revealed by Conformationally Sensitive Ligands

Por Li, Shih-Hon, Gorlatova, Natalia V., Lawrence, Daniel A., Schwartz, Bradford S.
Publicado em 2008

Plasma Lipoprotein Induction and Suppression of the Generation of Cellular Procoagulant Activity In Vitro: TWO PROCOAGULANT ACTIVITIES ARE PRODUCED BY PERIPHERAL BLOOD MONONUCLEAR...

Por Schwartz, Bradford S., Levy, Gary A., Curtiss, Linda K., Fair, Daryl S., Edgington, Thomas S.
Publicado em 1981

Neuroserpin Differentiates Between Forms of Tissue Type Plasminogen Activator via pH Dependent Deacylation

Por Carlson, Karen-Sue B., Nguyen, Lan, Schwartz, Kat, Lawrence, Daniel A., Schwartz, Bradford S.
Publicado no Front Cell Neurosci (2016)

Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy

Por Zhang, Michael Y, Churpek, Jane E, Keel, Siobán B, Walsh, Tom, Lee, Ming K, Loeb, Keith R, Gulsuner, Suleyman, Pritchard, Colin C, Sanchez-Bonilla, Marilyn, Delrow, Jeffrey J, Basom, Ryan S, Forouhar, Melissa, Gyurkocza, Boglarka, Schwartz, Bradford S, Neistadt, Barbara, Marquez, Rafael, Mariani, Christopher J, Coats, Scott A, Hofmann, Inga, Lindsley, R Coleman, Williams, David A, Abkowitz, Janis L, Horwitz, Marshall S, King, Mary-Claire, Godley, Lucy A, Shimamura, Akiko
Publicado no Nat Genet (2015)